533212 — GKB Ophthalmics Cashflow Statement
0.000.00%
- IN₹389.89m
- IN₹538.58m
- IN₹882.54m
- 46
- 62
- 16
- 35
Annual cashflow statement for GKB Ophthalmics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -18.4 | -9.28 | 19.5 | 1.39 | -27.8 |
Depreciation | |||||
Non-Cash Items | 13.5 | 21.8 | 8.49 | 10.6 | 10 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.35 | -80.5 | -3.96 | -68 | 30.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 32.7 | -36.6 | 50.7 | -27.7 | 42.2 |
Capital Expenditures | -38.6 | -63.3 | -47.6 | -16.6 | -20.8 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1.36 | 0.722 | 12.3 | 30.9 | 3.64 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -37.3 | -62.6 | -35.2 | 14.3 | -17.1 |
Financing Cash Flow Items | -14.4 | -20 | -14.5 | -16.5 | -19.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 43 | 27.7 | -16.6 | -21.9 | -16.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 38.4 | -71.5 | -1.21 | -35.3 | 8.68 |